CAVA Add to watchlist
$72.54 +0.00 (+0.00%)
Pre-Market: $69.97 2.57 (-3.54%)
Last updated: Jul 15, 2026 09:20
52-Week Range
$69.97
$43.41 $69.97 $98.79

Fundamentals Overview

CAVA Group, Inc. is in the middle of its 52-week range with premium valuation, trending downward today.

Valuation premium

P/E 134.4 P/B 10.05 P/S 6.34

Profitability

Net margin 4.8%

Risk (Beta)

1.69 — higher vol

Earnings & growth

EPS $0.52 Rev +59.4% Profit +378.9% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 64% confidence Risk: High Volatility — Beta 1.69. Consider smaller position size due to higher beta.

Supporting (Buy):

Sentiment improving (2 upgrades)

Pressures (Sell):

3M vs S&P 500: -26.5% · 3M vs Consumer Cyclical sector: -18.6% · Beta 1.69 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$8.15B
P/E (TTM)
134.39
EPS (TTM)
$0.52
Dividend Yield
N/A
52-Week Range
$43.41 - $98.79
Volume vs Avg
N/A
Beta
1.69

About

CAVA Group, Inc. is a company that oversees and runs a chain of Mediterranean restaurants. Their culinary offerings encompass a range of salads, savory dips, spreads, various toppings, and distinctive dressings. Beyond its dining establishments, the company distributes its products through whole food markets and other grocery retailers. Customers also have the option to utilize online food ordering services for convenience. Founded in 2006, CAVA Group, Inc. maintains its primary business operati...
Sector: Consumer Cyclical
Headquarters: US
Employees: 13,480
IPO Date: Jun 2023
Website: www.cava.com
Beta: 1.69 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: C. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 9, Equal Weight: 3, Hold: 1, Neutral: 6, Outperform: 6, Overweight: 5.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $-16.28; current price is $69.97. That’s a -123.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 134.39
PEG (TTM) N/A
P/B (TTM) 10.05
P/S (TTM) 6.34
P/FCF (TTM) 209.38
Liquidity & enterprise
Current Ratio (TTM) 2.65
Quick Ratio (TTM) 2.6
Cash Ratio (TTM) 1.77
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 4.79%
Gross margin (TTM) 18.6%
Operating margin (TTM) 7.17%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CAVA.

Analyst Sentiment at a Glance

C Sentiment Improving
Buy 9Equal Weight 3Hold 1Neutral 6Outperform 6Overweight 5
2 upgrades, 1 downgrade
Price Target Consensus
Current $69.97
Median $95.00
Consensus $92.59
Low consensus $74.00
High consensus $106.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS upgrade Neutral Buy 2026-06-10
TD Cowen maintain Buy Buy 2026-06-04
Argus Research upgrade Hold Buy 2026-05-22
DA Davidson maintain Neutral Neutral 2026-05-21
Telsey Advisory Group maintain Outperform Outperform 2026-05-20
Barclays maintain Equal Weight Equal Weight 2026-05-20
Stifel maintain Buy Buy 2026-05-20
Baird maintain Outperform Outperform 2026-05-20
Morgan Stanley maintain Equal Weight Equal Weight 2026-05-20
TD Cowen maintain Buy Buy 2026-05-20
RBC Capital maintain Outperform Outperform 2026-05-20
Roth Capital maintain Buy Buy 2026-05-20
Piper Sandler maintain Overweight Overweight 2026-05-20
Telsey Advisory Group maintain Outperform Outperform 2026-05-14
UBS maintain Neutral Neutral 2026-05-12
Citigroup maintain Neutral Neutral 2026-05-04
RBC Capital maintain Outperform Outperform 2026-05-01
JP Morgan maintain Overweight Overweight 2026-04-24
Morgan Stanley maintain Equal Weight Equal Weight 2026-04-21
Benchmark maintain Buy Buy 2026-04-20
Keybanc maintain Overweight Overweight 2026-04-20
Goldman Sachs maintain Neutral Neutral 2026-04-13
Mizuho maintain Neutral Neutral 2026-04-02
TD Cowen maintain Buy Buy 2026-04-02
Keybanc maintain Overweight Overweight 2026-03-03
Argus Research downgrade Buy Hold 2026-02-27
Piper Sandler maintain Overweight Overweight 2026-02-25
TD Cowen maintain Buy Buy 2026-02-25
Bernstein maintain Outperform Outperform 2026-02-25
Citigroup maintain Neutral Neutral 2026-02-25